TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.380
+0.060 (1.39%)
Oct 5, 2026, 4:00 PM EDT - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $269.7 million as of October 5, 2026. Its market cap has increased by 17.06% in one year.
Market Cap
269.70M
Enterprise Value
257.83M
1-Year Change
17.06%
Ranking
Category
Stock Price
$4.38
ChartMarket Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $269.70M, a decrease of -17.96%. That is a compound annual growth rate of -3.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 269.70M | -22.67% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viemed Healthcare | 347.75M |
| Quantum-Si incorporated | 339.27M |
| ClearPoint Neuro | 332.34M |
| Perspective Therapeutics | 315.06M |
| CapsoVision | 308.79M |
| Mobia Medical | 305.61M |
| Standard BioTools | 292.35M |
| Treace Medical Concepts | 285.50M |